| |
| Issue |
Title |
| |
| No 16 (2023) |
The role of hereditary thrombophilia in the development of venous thrombosis in combat trauma |
Abstract
PDF (Rus)
|
|
V. V. Salukhov, E. K. Gavrilov, N. A. Varavin, S. I. Kapustin, D. A. Bardakova |
| |
| No 16 (2023) |
Predictors of atrial thrombosis of persistent nonvalvular atrial fibrillation |
Abstract
PDF (Rus)
|
|
E. S. Mazur, V. V. Mazur, N. D. Bazhenov, Yu. A. Orlov |
| |
| No 16 (2023) |
Apixaban in patients with atrial fibrillation and acute coronary syndrome in elective percutaneous coronary intervention: what did the subanalysis of the AUGUSTUS trial add to our understanding? |
Abstract
PDF (Rus)
|
|
E. P. Panchenko |
| |
| No 17 (2022) |
Anticoagulant therapy with direct oral anticoagulants in the context of polypragmasy: a course to safety |
Abstract
PDF (Rus)
|
|
I. N. Sychev, L. V. Fedina, D. A. Gabrielyan, T. D. Rastvorova, E. V. Strigunkova, K. B. Mirzayev, D. A. Sychev |
| |
| No 14 (2021) |
Systematic errors in the choice of dose level of direct oral anticoagulants: urgency of an issue and approaches to its solution |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina |
| |
| No 14 (2021) |
The recovery of endothelial function in novel coronavirus infection COVID-19 (review) |
Abstract
PDF (Rus)
|
|
E. V. Roitman |
| |
| No 14 (2021) |
8-year follow-up of a successful outcome of massive pulmonary embolism with cardiogenic shock |
Abstract
PDF (Rus)
|
|
N. Yu. Semigolovskii, S. O. Mazurenko, M. O. Shabalina, S. N. Semigolovskii |
| |
| No 14 (2020) |
Apixaban in non-valvular atrial fibrillation and treatment of venous thromboembolism: universal safety advantage in different categories of patients |
Abstract
PDF (Rus)
|
|
I. S. Yavelov |
| |
| 1 - 8 of 8 Items |
|
